Raphael Pharmaceuticals LLC
Irving, TX
- UEI
- UE65NV6LGL73
- CAGE
- 83LF7
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 509 Bellah Dr, Irving, TX 75062, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of small molecule epigenetic therapeutics for prostate cancer - in this administrative supplement proposal… | National Cancer Institute (NIH) | $1,365,000 |
Quick answers
Is Raphael Pharmaceuticals LLC registered in SAM.gov?
Yes. Raphael Pharmaceuticals LLC's SAM.gov registration is active through May 8, 2027.
What is Raphael Pharmaceuticals LLC's most recent federal award?
Raphael Pharmaceuticals LLC's most recent federal grant award is Development of small molecule epigenetic therapeutics for prostate cancer - in this administrative supplement proposal… (R41CA261384), from National Cancer Institute (NIH), on August 16, 2021.
On GovTribe
See Raphael Pharmaceuticals LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors